- Prophylactic Effect of Erythropoietin Injection to Prevent Acute Mountain Sickness: An Open-Label Randomized Controlled Trial
-
Heo K, Kang JK, Choi CM, Lee MS, Noh KW, Kim SB
- KMID: 1734931
- J Korean Med Sci.
- 2014 Mar;29(3):416-422.
- doi: 10.3346/jkms.2014.29.3.416
This study was performed to evaluate whether increasing hemoglobin before ascent by prophylactic erythropoietin injections prevents acute mountain sickness (AMS). This open-label, randomized, controlled trial involved 39 healthy volunteers with... -
- CITED
-
- Close
- SHARE
-
- Close
- Erythropoietin Improves Long-Term Outcomes in Patients with Acute Kidney Injury after Coronary Artery Bypass Grafting
-
Oh SW, Chin HJ, Chae DW, Na KY
- KMID: 1372792
- J Korean Med Sci.
- 2012 May;27(5):506-511.
- doi: 10.3346/jkms.2012.27.5.506
Previous studies reported the beneficial effect of erythropoietin (EPO) in acute injuries. We followed patients with and without acute kidney injury (AKI) after coronary artery bypass grafting (CABG) and evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- Correction of Anemia with Continuous Erythropoietin Receptor Activator in Korean Patients on Long-Term Hemodialysis
-
Oh J, Joo KW, Chin HJ, Chae DW, Kim SG, Kim SJ, Chung W, Kim S, Huh W, Oh HY, Choi BS, Yang CW, Kim S
- KMID: 1796918
- J Korean Med Sci.
- 2014 Jan;29(1):76-83.
- doi: 10.3346/jkms.2014.29.1.76
Continuous erythropoietin receptor activator (CERA) is an erythropoietin with a long-half life. This study investigated the efficacy of CERA for correcting anemia in Korean patients on dialysis. Patients (> or... -
- CITED
-
- Close
- SHARE
-
- Close
